Business Wire

The Daiquiri Cocktail – First Mixed with BACARDÍ® Rum – Celebrates 125 Years

Share

This Daiquiri Day, family-owned Bacardi Limited raises a glass to celebrate the 125th birthday of the cocktail, still loved around the world by bartenders and consumers for its versatile recipe and refreshing taste. With an origin story that begins in Cuba with BACARDĺ® rum, the Daiquiri cocktail remains one of the most sought after cocktails claiming the #2 spot on the Bacardi Cocktail Trends Report of 2023.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230719440258/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

1930s BACARDÍ rum advertisement feat. the BACARDÍ Cocktail. Image courtesy of The Bacardi Archives

According to records from The Bacardi Archives, the story of the Daiquiri begins in the late 1890s during the Golden Age of Cocktails when many classic cocktail recipes were first invented and the height of the Spanish-American War in Cuba led Americans to travel to the island for the first time. In 1898, American mining engineer Jennings S. Cox was stationed in the copper mines near the sweltering Sierra Maestra mountains of the small Cuban town named Daiquirí. Looking for a way to cool down on a hot summer day, Cox reached for three local ingredients – white sugar, fresh lime juice, and BACARDÍ Carta Blanca rum – to shake up alongside crushed ice to make a refreshing drink. His colleague F.D Pagliuchi later recounted witnessing Cox mix up what would be the first BACARDÍ Daiquiri cocktail in Santiago to local Cuban newspaper El País, describing how they both suggested a short name to honor the town where the delicious drink was born: Daiquiri.

Cox first showcased his recipe to bartenders at the American Club bar in Santiago de Cuba, eventually taking the drink to the best bars in the city and soon across Cuba. Ice cold and served in a delicate coup glass, something usually reserved for the finest of Champagnes, the Daiquiri soon became the epitome of sophisticated drinking and the quintessential Cuban cocktail. By 1910, young American Navy officer Lucious Johnson had famously introduced the Daiquiri cocktail to the Army and Navy Club in Washington D.C. and soon after renowned Cuban bartender Constante Ribalaigua Vert introduced the frozen variation of the BACARDÍ Daiquiri to patrons at La Floridita bar in Havana, Cuba. With thousands of American tourists visiting the island of Cuba during Prohibition in the 1920s, the Daiquiri cocktail’s popularity spread to stratospheric new heights and its easily adaptable recipe expanded to include new variations that could be easily perfected by the at-home bartender.

“No cocktail is more synonymous with BACARDÍ rum than the Daiquiri,” states Rachel Guerin, Bacardi Heritage Curator. “One hundred years ago, the two were so closely associated that bar patrons ordering this delicious drink could simply ask for ‘a BACARDÍ Cocktail’ or even just ‘a BACARDÍ’ as depicted in BACARDÍ rum’s historic advertisement collection from the 20th century.”

Though it wouldn’t be long before the Daiquiri cocktail was in such high demand that it became the cocktail behind a landmark consumer rights case in 1936. With the rise in popularity of BACARDÍ and rum cocktails after Prohibition ended in 1933, it was discovered that some bars and restaurants in New York City tried to take advantage of consumers by substituting lesser quality rums for BACARDÍ when they asked for BACARDÍ Cocktails by name. Seeking to protect its brand and the rights of its consumers, Bacardi took legal action against these bars and restaurants, and on April 28, 1936 the Appellate Division of the New York Supreme Court ultimately ruled to affirm “Beyond a reasonable doubt, subterfuge and a fraud is subjected on the purchaser when BACARDÍ rum is left out of a drink listed as a BACARDÍ Cocktail.” The decision was so significant to consumers that BACARDÍ featured the ruling alongside the Daiquiri cocktail in a series of print advertising and marketing campaigns from the late 1930s under the theme “Nothing Takes Place of BACARDÍ Rum”.

“When it comes to BACARDÍ cocktails, the very best always were – and still are today – made with BACARDÍ rum,” states Dickie Cullimore, Global Brand Ambassador for BACARDÍ rum. “The secret to the perfect Daiquiri is to never hold back on ice, and, if possible, use a mix of cubes and crushed ice when shaking to achieve the best dilution and balance in flavors. Discover your own favorite Daiquiri variation by starting with the classic BACARDÍ rum recipe and experimenting with new ingredients to open up a world of endless cocktail possibilities.”

Today, the legacy of the Daiquiri cocktail continues to shine around the world, inspiring new recipe variations and feelings of summer and celebration. Discover the official Daiquiri recipe at Bacardi.com.

BACARDÍ Daiquiri

2 oz BACARDÍ Superior / Carta Blanca rum
1 oz Fresh lime juice
2 tsp Extra fine sugar

Directions: Place sugar and freshly pressed lime juice into a cocktail shaker and stir until the sugar has dissolved. Pour the BACARDÍ rum into the shaker and fill with half-cubed ice, followed by crushed ice. Place the lid on the shaker and shake vigorously until thoroughly chilled and shaker is ice cold to the touch. Pour into a chilled coup glass and enjoy responsibly.

About Bacardi Limited

Bacardi Limited, the world’s largest privately held international spirits company, produces, markets, and distributes internationally recognized spirits and wines. The Bacardi Limited portfolio comprises more than 200 brands and labels, including BACARDÍ® rum, PATRÓN® tequila, GREY GOOSE® vodka, DEWAR’S® Blended Scotch whisky, BOMBAY SAPPHIRE® gin, MARTINI® vermouth and sparkling wines, CAZADORES® 100% blue agave tequila, and other leading and emerging brands including WILLIAM LAWSON’S® Scotch whisky, D’USSÉ® Cognac, ANGEL’S ENVY® American straight whiskey, and ST-GERMAIN® elderflower liqueur. Founded more than 161 years ago in Santiago de Cuba, family-owned Bacardi Limited currently employs approximately 9,000, operates production facilities in 11 countries and territories, and sells its brands in more than 160 markets. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited. Visit www.bacardilimited.com or follow us on LinkedIn, Instagram or Twitter.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Jessica Merz, VP Corporate Communications, jmerz@bacardi.com
Erika Lam, Director Brand PR, eklam@bacardi.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)29.8.2025 13:00:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from a Phase 1/2 study (BGB-11417-201) of sonrotoclax, a next-generation and potentially best-in-class investigational BCL2 inhibitor, in adult patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL), following treatment with a Bruton’s tyrosine kinase inhibitor (BTKi) and anti-CD20 therapy. BeOne plans to present the full data at an upcoming medical meeting. “For people with relapsed or refractory mantle cell lymphoma, the disease is aggressive, the treatment landscape fragmented, and the outcomes unacceptably poor. These topline results for sonrotoclax underscore its potential to deliver meaningful and durable responses and offer the first BCL2 inhibitor for patients with R/R MCL, if approved,” said Lai Wang, PhD, Global Head of R&D, BeOne Medicines. “These data add to the remarkable progress we’ve seen over the past five years in treating B-cel

Oulu2026 – European Capital of Culture: Oulu to Unveil Full European Capital of Culture 2026 Programme – Live Stream on 4 September 202529.8.2025 11:46:00 EEST | Press release

Hundreds of partners are creating a year in which Northern Finland becomes a new hub of culture. The programme will offer something for everyone: large-scale exhibitions, festivals across all genres, world premieres, performing arts, village celebrations, permanent artworks, sports, and community events across a vast region of 40 municipalities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250829591577/en/ Oulu, with its 39 partner municipalities in Northern Finland, will step into the spotlight as European Capital of Culture 2026. The full programme will be officially launched on Thursday 4 September 2025 in Oulu, streamed live across Europe. The Oulu2026 programme is built around the theme of Cultural Climate Change, meaning a lasting enrichment of cultural life – connecting people through world-class experiences, creativity, and new ways of thinking. “2026 will be a transformative year – for our city, for Northern Finla

Nippon Sanso Holdings Group Unifies Global Brand Logo Launching the "NIPPON SANSO" Brand Worldwide29.8.2025 09:00:00 EEST | Press release

Nippon Sanso Holdings Corporation (President CEO: Toshihiko Hamada) will unify the brand logo for its industrial gas business globally and implement the change in stages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250828253560/en/ Until now, our group has operated industrial gas businesses worldwide using the same symbol mark, while adapting to each region. To further enhance recognition and understanding of our group as a unified entity among a broad range of stakeholders, and to maximize corporate value and achieve sustainable growth, we have decided to unify the brand for our industrial gas businesses as "NIPPON SANSO" and standardize the brand logo globally. Moving forward, we will continue striving to be a trusted company for all stakeholders as a globally recognized brand. *Please note that Thermos Group, which operates the consumer household goods business within our group, will not change its brand logo. *The log

TOM FORD Unveils Black Orchid Reserve Campaign Starring Tilda Swinton29.8.2025 07:35:00 EEST | Press release

The quest for exceptional rarity. Introducing Tilda Swinton for the new TOM FORD Black Orchid Reserve campaign. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250828507187/en/ “It is a profound honour for me to play a part in the history of TOM FORD’s legendary Black Orchid. Transformation, the blurring of boundaries and the celebration of magical properties have always drawn me close; Black Orchid Reserve is precisely such an enchantment.” — Tilda Swinton A celebrated actor and artist, Swinton is a singular presence known for her fearless artistry and transformative performances. An Academy Award, BAFTA and Golden Lion for Lifetime Achievement winner, Swinton defies conventions with elegance, intellect and a visionary approach to cinema. Her work transcends definition, shaping the culture through work in film, art and performance. TOM FORD creative director Haider Ackermann designed the campaign as a cinematic portrait of r

Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma28.8.2025 23:15:00 EEST | Press release

Novotech, a globally recognized full-service clinical research organization (CRO), is proud to have partnered with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ Pharma) in achieving a significant regulatory milestone: the approval of Anlotinib Hydrochloride Capsules for a new indication as a first-line treatment for unresectable locally advanced or metastatic soft tissue sarcoma (STS) in combination with chemotherapy. This approval marks the ninth indication for Anlotinib in China and represents the world’s first official approval of an Anlotinib-chemotherapy combination for first-line treatment of advanced or metastatic STS. Previously recommended as a second-line monotherapy by the Chinese Society of Clinical Oncology (CSCO) guidelines, Anlotinib was the only Grade I targeted therapy for STS. This new indication represents a significant advancement for patients who have not previously received systemic treatment, expanding access to more effective and targeted first-line the

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye